JPS5718615A - Anticataract agent - Google Patents

Anticataract agent

Info

Publication number
JPS5718615A
JPS5718615A JP9287680A JP9287680A JPS5718615A JP S5718615 A JPS5718615 A JP S5718615A JP 9287680 A JP9287680 A JP 9287680A JP 9287680 A JP9287680 A JP 9287680A JP S5718615 A JPS5718615 A JP S5718615A
Authority
JP
Japan
Prior art keywords
cystein
anticataract
salt
coom
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9287680A
Other languages
Japanese (ja)
Other versions
JPH0157092B2 (en
Inventor
Kazumi Ogata
Yujiro Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SENJIYU SEIYAKU KK
Senju Pharmaceutical Co Ltd
Original Assignee
SENJIYU SEIYAKU KK
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SENJIYU SEIYAKU KK, Senju Pharmaceutical Co Ltd filed Critical SENJIYU SEIYAKU KK
Priority to JP9287680A priority Critical patent/JPS5718615A/en
Publication of JPS5718615A publication Critical patent/JPS5718615A/en
Publication of JPH0157092B2 publication Critical patent/JPH0157092B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE: An anticataract that contains a cystein-glucuronate salt as an active principle, thus showing low toxicity.
CONSTITUTION: The objective anticataract contains a cystein-glucuronate salt of the formula (COOM1 is carboxylate salt; COOM2 are free carboxyl or carboxylate salt) and is made into a preparation such as tablets, pills for oral administration or injection solution or eye drop. The preparation is used to prevent the development of cataract or sotp the progress and the oral dose for adult is 1W5,000mg, preferably 10W2,000mg a day. The compound of the formula is obtained by reaction between cystein and gulcuronic acid in an aqueous medium in the presence of sodium hydroxide.
COPYRIGHT: (C)1982,JPO&Japio
JP9287680A 1980-07-07 1980-07-07 Anticataract agent Granted JPS5718615A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9287680A JPS5718615A (en) 1980-07-07 1980-07-07 Anticataract agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9287680A JPS5718615A (en) 1980-07-07 1980-07-07 Anticataract agent

Publications (2)

Publication Number Publication Date
JPS5718615A true JPS5718615A (en) 1982-01-30
JPH0157092B2 JPH0157092B2 (en) 1989-12-04

Family

ID=14066641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9287680A Granted JPS5718615A (en) 1980-07-07 1980-07-07 Anticataract agent

Country Status (1)

Country Link
JP (1) JPS5718615A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714322A1 (en) * 1986-05-01 1987-11-05 Senju Pharma Co PROPHYLACTIC AND THERAPEUTIC AGENT FOR HEPATITIC DISEASES
JPH02202818A (en) * 1988-12-09 1990-08-10 Allergan Inc Use of 2-substitution-thiazolizine -4-carboxylic acid or the like for cataract therapy

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714322A1 (en) * 1986-05-01 1987-11-05 Senju Pharma Co PROPHYLACTIC AND THERAPEUTIC AGENT FOR HEPATITIC DISEASES
FR2598082A1 (en) * 1986-05-01 1987-11-06 Senju Pharma Co PROPHYLACTIC AND THERAPEUTIC AGENT FOR THE TREATMENT OF HEPATIC DISORDERS
GB2189996A (en) * 1986-05-01 1987-11-11 Senju Pharma Co Cysteineglucuronic acid as a prophylactic and therapeutic agent
GB2189996B (en) * 1986-05-01 1990-05-02 Senju Pharma Co Prophylactic and therapeutic agent for hepatic disorder
JPH02202818A (en) * 1988-12-09 1990-08-10 Allergan Inc Use of 2-substitution-thiazolizine -4-carboxylic acid or the like for cataract therapy

Also Published As

Publication number Publication date
JPH0157092B2 (en) 1989-12-04

Similar Documents

Publication Publication Date Title
JPS5671073A (en) Imidazole derivative
FI945452A0 (en) An ibuprofen containing borne pharmaceutical composition and a process for its manufacture
US4455305A (en) Composition for the treatment of colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronic nonspecific colitis and diverticulitis and the use of salicylazobenzoic acid for the preparation of such compositions
IE43653L (en) Sequestration of oxygen dissolved in water
JPS5551020A (en) Remedy for rheumatism
JPS52128210A (en) Preparation of soft capsule for 1alpha-hydroxyvitamind derivatives
JPS5718615A (en) Anticataract agent
IT1229502B (en) COMPOSITIONS CONTAINING BISMUTO SUITABLE FOR THERAPEUTIC USE.
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
JPS57158719A (en) Rectal administration pharmaceutical
ES8501760A1 (en) Pyrrolidinone derivatives, their preparation and pharmaceutical compositions containing them.
JPS56152418A (en) Hypoglycemic agent
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation
JPS5731688A (en) Protoporphyrin germanium complex and its preparation
JPS5566509A (en) Carcinostatic
JPS5527133A (en) Drug comprising organosilicon compound as main constituent
JPS57108016A (en) Antithrombotic agent
JPS5569510A (en) Carcinostatic agent
GB1199758A (en) Arylsulphonyl-Semicarbazides and their production
JPS5489037A (en) Anti-ulcer agent
AU7971182A (en) Anthranilic acid derivatives
JPS5780315A (en) Absorption promotor for accelerating rectum absorption, base comprising it, and pharmaceutical preparation to be medicated to rectum
JPS57181012A (en) Drug composed of polyprenyl compound
JPS57108017A (en) Antithrombotic agent
JPS5634625A (en) Antitumorigenic agent